Thomas Papoian
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 10%
- Infectious Diseases top 10%
- Emergency Medicine top 5%
- Oncology
- Co-authors
- William LewisAnne ChomynB. GonzalezBaichun YangXi YangEugene H. HermanKazuyo TakedaSteven E. Lipshultz
- Topics
- Chemotherapy-induced cardiotoxicity and mitigation (6 papers)Pharmacogenetics and Drug Metabolism (3 papers)Cancer Treatment and Pharmacology (3 papers)
- Journals
- Journal of Clinical InvestigationNature Reviews Drug DiscoveryBiochemical and Biophysical Research Communications
- Partner nations
- United StatesThailand
In The Last Decade
Thomas Papoian
20 papers receiving 924 citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 428
- Cardiology and Cardiovascular Medicine 229
- Infectious Diseases 133
- Emergency Medicine 114
- Oncology 108
Countries citing papers authored by Thomas Papoian
This map shows the geographic impact of Thomas Papoian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Papoian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Papoian more than expected).
Fields of papers citing papers by Thomas Papoian
This network shows the impact of papers produced by Thomas Papoian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Papoian. The network helps show where Thomas Papoian may publish in the future.
Co-authorship network of co-authors of Thomas Papoian
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Papoian. A scholar is included among the top collaborators of Thomas Papoian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Papoian. Thomas Papoian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 23 | |
| 3 | 15 | |
| 4 | 32 | |
| 5 | 209 | |
| 6 | 23 | |
| 7 | 74 | |
| 8 | 47 | |
| 9 | 43 | |
| 10 | 32 | |
| 11 | Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity. | 116 |
| 12 | 162 | |
| 13 | Anthracyclines selectively decrease alpha cardiac actin mRNA abundance in the rat heart. | 5 |
| 14 | 10 | |
| 15 | Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. | 108 |
| 16 | Adriamycin cardiotoxicity in vivo. Selective alterations in rat cardiac mRNAs. | 20 |
| 17 | 19 | |
| 18 | 3 | |
| 19 | 5 | |
| 20 | Studies on cytotoxic and immunologic effects of viscum album (mistletoe). Abstr. | 5 |
About Thomas Papoian
Thomas Papoian is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Clinical Biochemistry, having authored 20 papers that have together received 954 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Virology (71 citations), Emergency Medicine (114 citations) and Cardiology and Cardiovascular Medicine (229 citations). Thomas Papoian has collaborated with scholars based in United States and Thailand. Frequent co-authors include William Lewis, Anne Chomyn, B. Gonzalez, Baichun Yang, Xi Yang, Eugene H. Herman, Kazuyo Takeda, Steven E. Lipshultz, V J Ferrans and Jun Zhang. Their work appears in journals such as Journal of Clinical Investigation, Nature Reviews Drug Discovery and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.